CGM for Type 2 Diabetes Through the Lens of Healthcare Professionals

Now, more people with diabetes (PWD) have access to continuous glucose monitoring (CGM) than ever before, even compared to one year ago.¹ This means that the demand for and use of CGM in primary care offices is rapidly increasing.

Results from randomized controlled trials demonstrate the effectiveness of CGM in reducing A1C in individuals with type 2 diabetes (T2D) taking multiple daily injections of insulin,² basal insulin only,³ and recently those treated with non-insulin therapies.

Given this evidence, how do we translate the research into clinical practice?

In this 1–2-minute video series, health care professionals share their approaches to using CGM in their patients with T2D, ways CGM impacts behavior change, and how to start the conversation with people who may benefit.

Video 1: Rationale for use of CGM in T2D as an educational tool for PWD to learn the impact of medications prescribed, food, and physical activity on their glucose.
Video 2: How CGM can be a tool that empowers the PWD to make informed health behavior decisions based on real-time glucose data.
Video 3: Discussion on unique populations, including older adults, who benefit from RT-CGM and alert functions.
Video 4: Examples of how and when to introduce CGM as a diabetes management tool and ways to discuss the glucose values with the PWD.

^{Centers for Medicare & Medicaid Services. Accessed January 25, 2024.}^{https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33822}^.
^{Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.}^{Ann Intern Med}^{. 2017;167(6):365-374. doi:10.7326/M16-2855}
^{Martens T, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.}^JAMA.^{2021;325(22):2262–2272.2.}
^{Grace T, Salyer J. Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.}^{Diabetes Technol Ther}^{. 2022;24(1):26-31. doi:10.1089/dia.2021.0212}